NEOGENOMICS
Summary
NeoGenomics operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 425 M
Avg. Deal Size£ 213 M
Senior Management
Kathryn B. McKenzie
CFO
Charlie Eidson
Investors Relations Manager
Denise E Pedulla
In-house Counsel
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite